Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-(3,7-Dimethyl-octa-2, 6-dienyl)¿6-ethylamino-3-hydroxy-5-pentyl-[1,4]benzoquinone |
---|---|
Date Designated: | 02/01/2018 |
Orphan Designation: | Treatment of Huntington’s Disease (HD) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Emerald Health Pharmaceuticals Inc. 5820 Nancy Ridge Drive San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-